Friday, 23 June 2023 06:38

This Week in Tech with Jeanne Destro-6-23-23: Gene Editing To Fight Sickle Cell Disease

Written by

Imagine some teeny-tiny little scissors. Now, imagine them snipping out "bad" genes that cause disease, and leaving only the good ones behind.

Sound farfetched?

Well, actually, it is not.

In fact, that's exactly what they're doing at Cleveland Clinic Children's, where a Sickle Cell Disease clinical trial involving CRSPR gene editing technology is now underway.

We talked about it, with Dr. Rabi Hanna, who is the Chairman of their Department of Pediatric Hematology, and Principal Investigator on the study:

 

DR. RABI HANNA

Dr. Rabi Hanna, Cleveland Clinic Children's 

CLEVELAND CLINIC CHILDRENS LOGO

Read 2632 times Last modified on Friday, 23 June 2023 07:50